Tevimbra
Tevimbra Approved for Some Patients With Unresectable or Metastatic ESCC
The FDA has approved tislelizumab (Tevimbra, BeiGene), in combination with platinum-containing chemotherapy, for ...
MARCH 4, 2025
Tevimbra Approved for Treatment of Gastric and Gastroesophageal Junction Cancers in Combination With Chemo
The FDA has approved tislelizumab-jsgr (Tevimbra, BeiGene), in combination with platinum and fluoropyrimidine-based ...
JANUARY 13, 2025
Tevimbra Approved for Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemo
The FDA approved tislelizumab-jsgr (Tevimbra, BeiGene) as monotherapy for adult patients with unresectable or ...
MARCH 19, 2024
Load more